Missing/wrong data?
Log in to edit
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
scientific article published on 21 March 2019
Author/s
author: Piotr Ponikowski, John McMurray, Marc S Sabatine, Mikaela Sjöstrand, Silvio E Inzucchi, Mikhail Kosiborod, David DeMets, DAPA-HF Committees and Investigators, Lars Køber
Work details
Publication date
March 21, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.